Hem › Myasthenia gravis › New York
Kliniska studier för Myasthenia gravis i New York
13 studier för Myasthenia gravis söker deltagare vid platser i New York.
Städer i New York
Officiell studietext (engelska)
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
- Mg0038 10106, Amherst
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07463521Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- Equity Medical, New York
RekryterarFas 3
Ålder 18 till 74 · Alla kön · Uppdaterad 25 sep. 2026 · NCT07217587ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis
- Dent Neurologic Institute - Amherst, Amherst
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT07673627ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
- Dent Neurologic Institute - Amherst, Amherst
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT07294170ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
- Dent Neurologic Institute - Amherst, Amherst
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 24 sep. 2026 · NCT07284420A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, New York
- TG Therapeutics Investigational Trial Site, Rochester
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT06680037A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
- Columbia University Irving Medical Center, New York
RekryterarFas 1
Ålder 18 till 75 · Alla kön · Uppdaterad 14 aug. 2026 · NCT07304154RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
- Columbia University, New York
- University of Rochester Medical Center, Rochester
RekryterarFas 1/2
Ålder 18 till 70 · Alla kön · Uppdaterad 13 aug. 2026 · NCT06359041Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1036, New York
- Site Number - 1034, New York
RekryterarFas 3
Ålder 18 till 80 · Alla kön · Uppdaterad 30 juli 2026 · NCT07039916A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
- Hospital for Special Surgery, New York
- Mount Sinai Health System, New York
- Montefiore Medical Center, The Bronx
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 18 juni 2026 · NCT06456580A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- Columbia University Irving Medical Center, New York
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 25 feb. 2026 · NCT06626919Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, New Hyde Park
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 18 feb. 2026 · NCT04202341The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
- Neurological Associates of Long Island, P.C., Lake Success
RekryterarFriska volontärer välkomna
Ålder 18 och äldre · Alla kön · Uppdaterad 11 apr. 2025 · NCT05564936Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.